Page last updated: 2024-09-02

procyanidin and HIV Infections

procyanidin has been researched along with HIV Infections in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (88.89)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Idowu, TO; Ogundaini, AO; Olubiyi, OO; Orhuah, G1
Cottreau, J; Crutchley, R; Garey, KW; Tucker, A; Yeo, QM1
Frampton, JE1
Chordia, P; MacArthur, RD1
Macarthur, RD1
Adegle, R; Amoa-Bosompem, M; Ampofo, W; Appiah, A; Appiah-Opong, R; Atchoglo, P; Barnor, J; Bonney, J; Brandful, J; Edoh, D; Frimpong, A; Hamano, A; Hori, T; Koram, K; Minta-Asare, K; Morinaga, O; Ndzinu, J; Nguyen Huu, T; Nyarko, A; Odoom, J; Ofosuhene, M; Okine, L; Owusu, BA; Sakyiamah, M; Shoyama, Y; Tuffour, I; Uota, S; Uto, T; Yamaoka, S; Yoshinaka, Y1
Biswal, S1
Castro, JG; Chin-Beckford, N1
Grierson, DS; Ndip, RN; Otang, WM1

Reviews

5 review(s) available for procyanidin and HIV Infections

ArticleYear
Crofelemer: a review of its use in the management of non-infectious diarrhoea in adult patients with HIV/AIDS on antiretroviral therapy.
    Drugs, 2013, Volume: 73, Issue:10

    Topics: Anti-Retroviral Agents; Antidiarrheals; Diarrhea; HIV Infections; Humans; Plant Extracts; Proanthocyanidins; Randomized Controlled Trials as Topic

2013
Crofelemer, a novel agent for treatment of non-infectious diarrhea in HIV-infected persons.
    Expert review of gastroenterology & hepatology, 2013, Volume: 7, Issue:7

    Topics: Animals; Anti-HIV Agents; Chloride Channels; Diarrhea; Gastrointestinal Agents; Gastrointestinal Tract; HIV Enteropathy; HIV Infections; Humans; Medication Adherence; Proanthocyanidins; Quality of Life; Risk Factors; Treatment Outcome

2013
Management of noninfectious diarrhea associated with HIV and highly active antiretroviral therapy.
    The American journal of managed care, 2013, Volume: 19, Issue:12 Suppl

    Topics: Anti-HIV Agents; Antidiarrheals; Antiretroviral Therapy, Highly Active; Clinical Trials, Phase III as Topic; Diarrhea; Disease Management; Drug Approval; Female; HIV Infections; Humans; Male; Proanthocyanidins; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome; United States; United States Food and Drug Administration

2013
Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective.
    Recent patents on anti-infective drug discovery, 2014, Volume: 9, Issue:2

    Topics: Antidiarrheals; Chloride Channels; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; HIV Infections; Humans; Patents as Topic; Proanthocyanidins

2014
Crofelemer for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy.
    Expert review of clinical pharmacology, 2015, Volume: 8, Issue:6

    Topics: Adult; Anti-HIV Agents; Antidiarrheals; Chronic Disease; Diarrhea; HIV Infections; Humans; Medication Adherence; Proanthocyanidins; Quality of Life

2015

Other Studies

4 other study(ies) available for procyanidin and HIV Infections

ArticleYear
Computational Prospecting for the Pharmacological Mechanism of Activity: HIV-1 Inhibition by Ixoratannin A-2.
    Current computer-aided drug design, 2020, Volume: 16, Issue:4

    Topics: Antiviral Agents; HIV Infections; HIV-1; Humans; Molecular Docking Simulation; Proanthocyanidins; Protein Interaction Maps; Thermodynamics

2020
Crofelemer, a novel antisecretory agent approved for the treatment of HIV-associated diarrhea.
    Drugs of today (Barcelona, Spain : 1998), 2013, Volume: 49, Issue:4

    Topics: Animals; Antidiarrheals; Diarrhea; Drug Interactions; HIV Infections; Humans; Proanthocyanidins

2013
Procyanidin trimer C1 derived from Theobroma cacao reactivates latent human immunodeficiency virus type 1 provirus.
    Biochemical and biophysical research communications, 2015, Apr-03, Volume: 459, Issue:2

    Topics: Biflavonoids; Cacao; Catechin; Cell Line; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Indoles; Jurkat Cells; Maleimides; MAP Kinase Signaling System; Microbial Sensitivity Tests; Models, Biological; NF-kappa B; Phytotherapy; Plants, Medicinal; Proanthocyanidins; Protein Kinase C; Protein Kinase Inhibitors; Proviruses; Virus Activation; Virus Latency

2015
Phytochemical studies and antioxidant activity of two South African medicinal plants traditionally used for the management of opportunistic fungal infections in HIV/AIDS patients.
    BMC complementary and alternative medicine, 2012, Apr-13, Volume: 12

    Topics: Antifungal Agents; Antioxidants; Flavonoids; HIV Infections; Humans; Liliaceae; Opportunistic Infections; Phytotherapy; Plant Bark; Plant Extracts; Plant Leaves; Plants, Medicinal; Proanthocyanidins; Rosales; South Africa

2012